InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,887.20
(
-1.04%
)
US TECH 100
20,034.40
(
-1.54%
)
Dow Jones
43,525.64
(
-0.51%
)
Brent Oil
72.11
(
-0.15%
)
Bitcoin
88,322.95
(
1.11%
)
Post# of 253612
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 90613

Monday, 02/15/2010 5:36:18 AM

Monday, February 15, 2010 5:36:18 AM

Post# of 253612
CEPH gets diversification to its brands portfolio and a footprint in ex-US regions such as Switzerland, Portugal, and the Middle-east where they had no presence. There are tax benefits and it also opens the way to biosimilars. My primary interest is in Treanda (not in CEPH). I think it might in time be used even outside of NHL/CLL in solid tumors where alkylating agents are commonly used.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up